About: Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa
Creator	Guarner, Jeannette Vanairsdale, Sharon Isakov, Alexander Kozarsky, Phyllis Anderson, Evan Baker, Esther Gillespie, Darria Meloy, Patrick Espinoza, Tamara Fairley, Jessica Jacob, Jesse Kraft, Colleen Steinberg, James Wu, Henry
source	Medline; PMC
abstract	Background. The 2014–2015 Ebola epidemic in West Africa had global impact beyond the primarily affected countries of Guinea, Liberia, and Sierra Leone. Other countries, including the United States, encountered numerous patients who arrived from highly affected countries with fever or other signs or symptoms consistent with Ebola virus disease (EVD). Methods. We describe our experience evaluating 25 travelers who met the US Centers for Disease Control and Prevention case definition for a person under investigation (PUI) for EVD from July 20, 2014 to January 28, 2015. All patients were triaged and evaluated under the guidance of institutional protocols to the emergency department, outpatient tropical medicine clinic, or Emory's Ebola treatment unit. Strict attention to infection control and early involvement of public health authorities guided the safe evaluation of these patients. Results. None were diagnosed with EVD. Respiratory illnesses were common, and 8 (32%) PUI were confirmed to have influenza. Four patients (16%) were diagnosed with potentially life-threatening infections or conditions, including 3 with Plasmodium falciparum malaria and 1 with diabetic ketoacidosis. Conclusions. In addition to preparing for potential patients with EVD, Ebola assessment centers should consider other life-threatening conditions requiring urgent treatment, and travelers to affected countries should be strongly advised to seek pretravel counseling. Furthermore, attention to infection control in all aspects of PUI evaluation is paramount and has presented unique challenges. Lessons learned from our evaluation of potential patients with EVD can help inform preparations for future outbreaks of highly pathogenic communicable diseases.
has issue date	2016-01-18(xsd:dateTime)
bibo:doi	10.1093/ofid/ofw005
bibo:pmid	26925428
has license	cc-by-nc-nd
sha1sum (hex)	879df084e06fcce1980e3f73c36748068b39f049
schema:url	https://doi.org/10.1093/ofid/ofw005
resource representing a document's title	Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa
has PubMed Central identifier	PMC4766384
has PubMed identifier	26925428
schema:publication	Open Forum Infect Dis
resource representing a document's body	covid:879df084e06fcce1980e3f73c36748068b39f049#body_text
is schema:about of	named entity 'Ebola' named entity 'public health' named entity 'PPE' named entity 'life-threatening' named entity 'West Africa' named entity 'Ebola' named entity 'hygiene' named entity 'EVD' named entity 'North American' named entity 'Laboratory testing' named entity 'Emory University Hospital Midtown' named entity 'healthcare facilities' named entity 'Influenza-like illness' named entity 'triage' named entity 'influenza vaccine' named entity 'screening programs' named entity 'gastrointestinal illnesses' named entity 'EVD' named entity 'outpatient' named entity 'tropical medicine' named entity 'Ebola' named entity 'EVD' named entity 'EVD' named entity 'EVD' named entity '21 days' named entity 'vomiting' named entity 'West African' named entity 'public health' named entity 'preventative measures' named entity 'health department' named entity 'treatment centers' named entity 'affected areas' named entity 'DKA' named entity 'risk factors' named entity 'Triage' named entity 'Prophylactic' named entity 'noninfectious' named entity 'triage' named entity 'EVD' named entity 'Fever' named entity 'PPE' named entity 'influenza season' named entity '21 days' named entity 'epidemiologic' named entity 'virus infections' named entity 'virus' named entity 'infectious disease' named entity 'influenza' named entity 'avian influenza' named entity 'infection' named entity 'fever' named entity 'malaria' named entity 'noninfectious' named entity 'epidemiologic' named entity 'Salt Lake City' named entity 'affected areas' named entity 'endemic areas' named entity 'influenza season' named entity 'Ebola' named entity 'public health' named entity 'EVD' named entity 'hospital Infection' named entity 'virus' named entity 'emergency department' named entity 'infection' named entity 'EVD' named entity 'EVD' named entity 'EVD'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software